Naltrexone And Bupropion
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 793
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| NB32 | 199 participants | 64 participants | 43 participants | n/r | n/r |
| Placebo | 21 participants | 13 participants | 15 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.